Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

602 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-12-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To estimate the rates of percutaneous coronary intervention (PCI) outcomes in patients after drug-eluting stents implantation who take statins.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Prospective Study OPTIMA II - Follow-up

NCT02099565

Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)

COMPLETED

Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI

NCT01293097

Non-ST Segment Elevation Myocardial Infarction Unstable Angina Pectoris Stable Angina Pectoris

COMPLETED PHASE4

Effects of Short-term Intensive Statin Therapy on Lipid Levels

NCT07344610

Ischemic Stroke

RECRUITING

Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation

NCT01557075

Drug-eluting Stent (DES)

UNKNOWN PHASE4

Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI

NCT01033058

STEMI

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyslipidemia Coronary Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Male or female \> 18 year of age with indication to PCI

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stable angina with indication to PCI
* Hospitalization to Russian Cardiological Research Center (РКНПК) for PCI procedure with drug-eluting stents implantation
* Statin therapy initiated for at least one month prior to PCI
* Written informed consent provided prior the start of participation in the study.

Exclusion Criteria

* Subjects who are unwilling or unable to provide informed consent.
* Presence of ACS during the current hospitalization
* Severe CHF (NYHA III/IV) or LVEF\<40 %
* Stroke within 6 months before PCI
* Acute or chronic inflammatory disease
* Anti-inflammatory medications intake, with the exception of aspirin
* Severe liver or muscle disease
* Severe kidney disease / renal failure with creatinine \> 3 mg/dl
* History of oncologic disease
* Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No